<DOC>
	<DOCNO>NCT00652028</DOCNO>
	<brief_summary>The objective study characterize pharmacokinetic pharmacodynamic profile dexmedetomidine administer intravenous load dose follow continuous intravenous infusion pediatric subject age ≥2 &lt; 17 year old .</brief_summary>
	<brief_title>Pharmacokinetics Pharmacodynamics Dexmedetomidine Pediatrics Subjects</brief_title>
	<detailed_description>This phase II , open-label , multicenter , escalate dose study evaluate pharmacokinetics pharmacodynamics dexmedetomidine pediatric subject . The study population consist initially intubate mechanically ventilated pediatric subject , age ≥2 &lt; 17 year old , require sedation intensive care set minimum 6 hour . Subjects divide two group base age : Group I consist subject age ≥2 &lt; 6 year old Group II subject age ≥6 &lt; 17 year old . Within group four escalate dosing level . Both group enroll simultaneously ; however within group , next dose level begin enroll subject complete previous dose level Data Safety Monitoring Board ( DSMB ) approve enrollment next level . The level sedation assess use Ramsay Sedation Scale ( RSS ) . Based score , clinical judgment , additional sedation midazolam administer accord label . Pain assess use Faces , Legs , Arms , Cry &amp; Consolability ( FLACC ) scale . Venous blood sample pharmacokinetic analysis obtain designate time . The pharmacodynamic safety measure monitor pharmacodynamic impact dexmedetomidine tracheal extubation also explore subject extubated within 24 hour .</detailed_description>
	<mesh_term>Fentanyl</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>Initially intubate mechanically ventilated pediatric subject intensive care set anticipate require minimum 6 hour continuous intravenous sedation . Age : subject must fit one follow age range screen : ≥2 year old &lt; 6 year old ≥6 year old &lt; 17 year old If female , subject nonlactating either : 1 . Not childbearing potential , defined premenarche , surgically sterile due bilateral tubal ligation , bilateral oophorectomy hysterectomy . 2 . Of childbearing potential pregnant time baseline . Subject 's parent ( ) legal guardian ( ) has/have voluntarily sign date informed consent document approve Institutional Review Board . Assent obtain ageappropriate accord state regulation . Pediatric subject neurological condition prohibit evaluation sedation Diminished consciousness increase intracranial pressure . Extensive brain surgery ( surgery require intracranial pressure monitor ) . Diminished cognitive function per PI 's discretion . Subjects immobility neuromuscular disease continuous infusion neuromuscular block agent . Weight &lt; 10 kg . Subjects second degree third degree heart block unless subject pacemaker pacing wire . Hepatic impairment Serum glutamic pyruvic transaminase/Alanine aminotransferase ( SGPT/ALT ) &gt; 100 U/L Hypotension base repeat assessment prior start study drug : Age ≥2 year old ≤12 year old : systolic blood pressure ( SBP ) &lt; 80 mmHg Age &gt; 12 year old &lt; 17 year old : SBP &lt; 90 mmHg Preexisting bradycardia prior start study drug define : Age ≥2 year old ≤6 year old : ≤70 beat per minute ( bpm ) Age &gt; 6 year old ≤12 year old : ≤60 bpm Age &gt; 12 year old ≤16 year old : ≤50 bpm Acute thermal burn involve 15 percent total body surface area . Subjects know allergy dexmedetomidine , midazolam ( MDZ ) fentanyl . Subjects life expectancy &lt; 72 hour . Subjects expect hemodialysis ( continuous hemofiltration ) peritoneal dialysis within 48 hour . Subjects treat α2 agonists/antagonists within two week . Subjects spinal cord injury T5 . Subjects receive another investigational drug within past 30 day . Subjects nicotine replacement therapy . Subjects , opinion investigator , may able comply safety monitoring requirement clinical study .</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Pharmacodynamics</keyword>
	<keyword>Escalating dose</keyword>
	<keyword>Dexmedotimidine</keyword>
	<keyword>Intubated</keyword>
	<keyword>Mechanically ventilate</keyword>
	<keyword>Pediatrics</keyword>
</DOC>